137 related articles for article (PubMed ID: 36113628)
1. Characterizing M-protein light chain glycosylation via mass spectrometry.
Miller ID; Kohlhagen MC; Ladwig PM; Dasari S; Kumar S; Dispenzieri A; Willrich MAV; Murray DL
Clin Biochem; 2022; 109-110():11-16. PubMed ID: 36113628
[TBL] [Abstract][Full Text] [Related]
2. Sensitive and robust MALDI-TOF-MS glycomics analysis enabled by Girard's reagent T on-target derivatization (GTOD) of reducing glycans.
Zhang Y; Wang B; Jin W; Wen Y; Nan L; Yang M; Liu R; Zhu Y; Wang C; Huang L; Song X; Wang Z
Anal Chim Acta; 2019 Feb; 1048():105-114. PubMed ID: 30598139
[TBL] [Abstract][Full Text] [Related]
3. Detection of serum M-protein in acetonitrile precipitates by MALDI-TOF mass spectrometry: A novel, low-cost methodology.
Mehra N; Gopisetty G; Subramani J; Dhanasekar S; Rajamanickam A; Perumal Kalaiyarasi J; Karunakaran P; Kannan K; Rajaraman S; Rajkumar T
Ann Clin Biochem; 2023 Sep; 60(5):339-348. PubMed ID: 37158306
[TBL] [Abstract][Full Text] [Related]
4. MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients.
Mellors PW; Dasari S; Kohlhagen MC; Kourelis T; Go RS; Muchtar E; Gertz MA; Kumar SK; Buadi FK; Willrich MAV; Lust JA; Kapoor P; Lacy MQ; Dingli D; Hwa Y; Fonder A; Hobbs M; Hayman S; Warsame R; Leung NR; Lin Y; Gonsalves W; Siddiqui M; Kyle RA; Rajkumar SV; Murray DL; Dispenzieri A
Blood Cancer J; 2021 Mar; 11(3):50. PubMed ID: 33664227
[TBL] [Abstract][Full Text] [Related]
5. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
Franc V; Řehulka P; Raus M; Stulík J; Novak J; Renfrow MB; Šebela M
J Proteomics; 2013 Oct; 92():299-312. PubMed ID: 23891555
[TBL] [Abstract][Full Text] [Related]
6. Profiling N-glycans of the egg jelly coat of the sea urchin Paracentrotus lividus by MALDI-TOF mass spectrometry and capillary liquid chromatography electrospray ionization-ion trap tandem mass spectrometry systems.
Şahar U; Deveci R
Mol Reprod Dev; 2017 May; 84(5):401-407. PubMed ID: 28295836
[TBL] [Abstract][Full Text] [Related]
7. Direct Mass Spectrometry-Based Detection and Antibody Sequencing of Monoclonal Gammopathy of Undetermined Significance from Patient Serum: A Case Study.
Peng W; den Boer MA; Tamara S; Mokiem NJ; van der Lans SPA; Bondt A; Schulte D; Haas PJ; Minnema MC; Rooijakkers SHM; van Zuilen AD; Heck AJR; Snijder J
J Proteome Res; 2023 Sep; 22(9):3022-3028. PubMed ID: 37499263
[TBL] [Abstract][Full Text] [Related]
8. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy.
Barnidge DR; Dasari S; Botz CM; Murray DH; Snyder MR; Katzmann JA; Dispenzieri A; Murray DL
J Proteome Res; 2014 Mar; 13(3):1419-27. PubMed ID: 24467232
[TBL] [Abstract][Full Text] [Related]
9. Direct Detection of Monoclonal Free Light Chains in Serum by Use of Immunoenrichment-Coupled MALDI-TOF Mass Spectrometry.
Sepiashvili L; Kohlhagen MC; Snyder MR; Willrich MAV; Mills JR; Dispenzieri A; Murray DL
Clin Chem; 2019 Aug; 65(8):1015-1022. PubMed ID: 31171529
[TBL] [Abstract][Full Text] [Related]
10. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
Murray D; Kumar SK; Kyle RA; Dispenzieri A; Dasari S; Larson DR; Vachon C; Cerhan JR; Rajkumar SV
Blood Cancer J; 2019 Dec; 9(12):102. PubMed ID: 31836698
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of glycation and glycation sites of lysozyme by matrix-assisted laser desorption/ionization time of flight/time-of-flight mass spectrometry and Liquid chromatography-electrospray ionization tandem mass spectrometry.
Ruan ED; Wang H; Ruan Y; Juáreza M
Eur J Mass Spectrom (Chichester); 2014; 20(4):327-36. PubMed ID: 25420345
[TBL] [Abstract][Full Text] [Related]
12. Unusual N-glycan structures in alpha-mannosidase II/IIx double null embryos identified by a systematic glycomics approach based on two-dimensional LC mapping and matrix-dependent selective fragmentation method in MALDI-TOF/TOF mass spectrometry.
Hato M; Nakagawa H; Kurogochi M; Akama TO; Marth JD; Fukuda MN; Nishimura S
Mol Cell Proteomics; 2006 Nov; 5(11):2146-57. PubMed ID: 16899540
[TBL] [Abstract][Full Text] [Related]
13. MALDI-TOF mass spectrometry can distinguish immunofixation bands of the same isotype as monoclonal or biclonal proteins.
Fatica EM; Martinez M; Ladwig PM; Murray JD; Kohlhagen MC; Kyle RA; Kourelis T; Lust JA; Snyder MR; Dispenzieri A; Murray DL; Willrich MAV
Clin Biochem; 2021 Nov; 97():67-73. PubMed ID: 34384797
[TBL] [Abstract][Full Text] [Related]
14. Analysis of N- and O-linked glycans from glycoproteins using MALDI-TOF mass spectrometry.
Morelle W; Faid V; Chirat F; Michalski JC
Methods Mol Biol; 2009; 534():5-21. PubMed ID: 19277556
[TBL] [Abstract][Full Text] [Related]
15. Methods in enzymology: O-glycosylation of proteins.
Peter-Katalinić J
Methods Enzymol; 2005; 405():139-71. PubMed ID: 16413314
[TBL] [Abstract][Full Text] [Related]
16. A MATLAB-based app to improve LC-MS/MS data analysis for N-linked glycan peak identification.
Dhingra A; Schaeffer Z; Majewska Nepomuceno NI; Au J; Ahn J
BMC Bioinformatics; 2023 Jun; 24(1):259. PubMed ID: 37330473
[TBL] [Abstract][Full Text] [Related]
17. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.
Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH
Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689
[TBL] [Abstract][Full Text] [Related]
18. N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression.
Dispenzieri A; Larson DR; Rajkumar SV; Kyle RA; Kumar SK; Kourelis T; Arendt B; Willrcih M; Dasari S; Murray D
Leukemia; 2020 Oct; 34(10):2749-2753. PubMed ID: 32594098
[TBL] [Abstract][Full Text] [Related]
19. Comparison of planar SDS-PAGE, CGE-on-a-chip, and MALDI-TOF mass spectrometry for analysis of the enzymatic de-N-glycosylation of antithrombin III and coagulation factor IX with PNGase F.
Müller R; Marchetti M; Kratzmeier M; Elgass H; Kuschel M; Zenker A; Allmaier G
Anal Bioanal Chem; 2007 Nov; 389(6):1859-68. PubMed ID: 17879089
[TBL] [Abstract][Full Text] [Related]
20. The potential role of mass spectrometry for the identification and monitoring of patients with plasma cell disorders: Where are we now and which questions remain unanswered?
Giles HV; Wechalekar A; Pratt G
Br J Haematol; 2022 Aug; 198(4):641-653. PubMed ID: 35514140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
